Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India.
<h4>Background</h4>Xpert MTB/RIF is an automated cartridge-based nucleic acid amplification test that has demonstrated its potential to detect tuberculosis and rifampicin resistance with high accuracy. To assist scale-up decisions in India, a feasibility assessment of Xpert MTB/RIF imple...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/ed66ce922a7f43159eed36f5f65af6c4 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:ed66ce922a7f43159eed36f5f65af6c4 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:ed66ce922a7f43159eed36f5f65af6c42021-11-18T08:30:57ZFeasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India.1932-620310.1371/journal.pone.0089301https://doaj.org/article/ed66ce922a7f43159eed36f5f65af6c42014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24586675/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Xpert MTB/RIF is an automated cartridge-based nucleic acid amplification test that has demonstrated its potential to detect tuberculosis and rifampicin resistance with high accuracy. To assist scale-up decisions in India, a feasibility assessment of Xpert MTB/RIF implementation was conducted within microscopy centres of 18 RNTCP TB units.<h4>Methods</h4>As part of programme-based demonstration of Xpert MTB/RIF implementation, we recorded and analysed association between key implementation factors and the ability of test to produce valid results. Factors contributing to test failures were analysed from GeneXpert software data which provides 'failure codes' and causes for test failures.<h4>Results</h4>From March'12 to January'13, total 40,035 suspects were tested by Xpert MTB/RIF, and 39,680 (99.1%) received valid results (Cumulative: 37157 (92.8%) on first attempt, 39410 (98.4%) on second attempt, 39637 (99.0%) on third attempt and 39680 (99.1%) on more attempts). Overall initial test failure was 2,878 (7.2% (4%-17%)); of these, 2,594 (90.1%) were re-tested and produced valid results. Most frequent reason of test failure was inadequate sample processing or equipment malfunction (3.9%). Other reasons included power failure (1.1%), cartridge integrity/component failure (0.8%), device-computer communication error (0.5%), and temperature-related errors (0.08%). Significant variation was observed in failure rates both across instruments and over time; furthermore, substantial variation was observed in failure rate in two cartridges lots.<h4>Conclusion</h4>Installation required minimal infrastructure modifications and concerns about adequacy of human resources under public sector facilities and temperature extremes proved unfounded. Under routine conditions, Xpert MTB/RIF provided 99.1% valid results in TB suspects with low overall failure rates (7.2% initial failure, 0.9% final failure); devices provided valuable real-time feedback on reasons for test failure, which were used for rapid corrective action. High modular replacement (32%) and inter-lot cartridge performance variation remain sources of concern, and warrant close monitoring of failure rates as a key quality indicator.Neeraj RaizadaK S SachdevaAchuthan SreenivasBhavin VaderaR S GuptaMalik ParmarShubhangi KulsangeAmeet BabreRahul ThakurChristen GrayRanjani RamachandranUmesh AlavadiMayank GhediaBalasangameshwara VolleporePuneet DewanCatharina BoehmeC N ParamsivanPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 2, p e89301 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Neeraj Raizada K S Sachdeva Achuthan Sreenivas Bhavin Vadera R S Gupta Malik Parmar Shubhangi Kulsange Ameet Babre Rahul Thakur Christen Gray Ranjani Ramachandran Umesh Alavadi Mayank Ghedia Balasangameshwara Vollepore Puneet Dewan Catharina Boehme C N Paramsivan Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India. |
| description |
<h4>Background</h4>Xpert MTB/RIF is an automated cartridge-based nucleic acid amplification test that has demonstrated its potential to detect tuberculosis and rifampicin resistance with high accuracy. To assist scale-up decisions in India, a feasibility assessment of Xpert MTB/RIF implementation was conducted within microscopy centres of 18 RNTCP TB units.<h4>Methods</h4>As part of programme-based demonstration of Xpert MTB/RIF implementation, we recorded and analysed association between key implementation factors and the ability of test to produce valid results. Factors contributing to test failures were analysed from GeneXpert software data which provides 'failure codes' and causes for test failures.<h4>Results</h4>From March'12 to January'13, total 40,035 suspects were tested by Xpert MTB/RIF, and 39,680 (99.1%) received valid results (Cumulative: 37157 (92.8%) on first attempt, 39410 (98.4%) on second attempt, 39637 (99.0%) on third attempt and 39680 (99.1%) on more attempts). Overall initial test failure was 2,878 (7.2% (4%-17%)); of these, 2,594 (90.1%) were re-tested and produced valid results. Most frequent reason of test failure was inadequate sample processing or equipment malfunction (3.9%). Other reasons included power failure (1.1%), cartridge integrity/component failure (0.8%), device-computer communication error (0.5%), and temperature-related errors (0.08%). Significant variation was observed in failure rates both across instruments and over time; furthermore, substantial variation was observed in failure rate in two cartridges lots.<h4>Conclusion</h4>Installation required minimal infrastructure modifications and concerns about adequacy of human resources under public sector facilities and temperature extremes proved unfounded. Under routine conditions, Xpert MTB/RIF provided 99.1% valid results in TB suspects with low overall failure rates (7.2% initial failure, 0.9% final failure); devices provided valuable real-time feedback on reasons for test failure, which were used for rapid corrective action. High modular replacement (32%) and inter-lot cartridge performance variation remain sources of concern, and warrant close monitoring of failure rates as a key quality indicator. |
| format |
article |
| author |
Neeraj Raizada K S Sachdeva Achuthan Sreenivas Bhavin Vadera R S Gupta Malik Parmar Shubhangi Kulsange Ameet Babre Rahul Thakur Christen Gray Ranjani Ramachandran Umesh Alavadi Mayank Ghedia Balasangameshwara Vollepore Puneet Dewan Catharina Boehme C N Paramsivan |
| author_facet |
Neeraj Raizada K S Sachdeva Achuthan Sreenivas Bhavin Vadera R S Gupta Malik Parmar Shubhangi Kulsange Ameet Babre Rahul Thakur Christen Gray Ranjani Ramachandran Umesh Alavadi Mayank Ghedia Balasangameshwara Vollepore Puneet Dewan Catharina Boehme C N Paramsivan |
| author_sort |
Neeraj Raizada |
| title |
Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India. |
| title_short |
Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India. |
| title_full |
Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India. |
| title_fullStr |
Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India. |
| title_full_unstemmed |
Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India. |
| title_sort |
feasibility of decentralised deployment of xpert mtb/rif test at lower level of health system in india. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2014 |
| url |
https://doaj.org/article/ed66ce922a7f43159eed36f5f65af6c4 |
| work_keys_str_mv |
AT neerajraizada feasibilityofdecentraliseddeploymentofxpertmtbriftestatlowerlevelofhealthsysteminindia AT kssachdeva feasibilityofdecentraliseddeploymentofxpertmtbriftestatlowerlevelofhealthsysteminindia AT achuthansreenivas feasibilityofdecentraliseddeploymentofxpertmtbriftestatlowerlevelofhealthsysteminindia AT bhavinvadera feasibilityofdecentraliseddeploymentofxpertmtbriftestatlowerlevelofhealthsysteminindia AT rsgupta feasibilityofdecentraliseddeploymentofxpertmtbriftestatlowerlevelofhealthsysteminindia AT malikparmar feasibilityofdecentraliseddeploymentofxpertmtbriftestatlowerlevelofhealthsysteminindia AT shubhangikulsange feasibilityofdecentraliseddeploymentofxpertmtbriftestatlowerlevelofhealthsysteminindia AT ameetbabre feasibilityofdecentraliseddeploymentofxpertmtbriftestatlowerlevelofhealthsysteminindia AT rahulthakur feasibilityofdecentraliseddeploymentofxpertmtbriftestatlowerlevelofhealthsysteminindia AT christengray feasibilityofdecentraliseddeploymentofxpertmtbriftestatlowerlevelofhealthsysteminindia AT ranjaniramachandran feasibilityofdecentraliseddeploymentofxpertmtbriftestatlowerlevelofhealthsysteminindia AT umeshalavadi feasibilityofdecentraliseddeploymentofxpertmtbriftestatlowerlevelofhealthsysteminindia AT mayankghedia feasibilityofdecentraliseddeploymentofxpertmtbriftestatlowerlevelofhealthsysteminindia AT balasangameshwaravollepore feasibilityofdecentraliseddeploymentofxpertmtbriftestatlowerlevelofhealthsysteminindia AT puneetdewan feasibilityofdecentraliseddeploymentofxpertmtbriftestatlowerlevelofhealthsysteminindia AT catharinaboehme feasibilityofdecentraliseddeploymentofxpertmtbriftestatlowerlevelofhealthsysteminindia AT cnparamsivan feasibilityofdecentraliseddeploymentofxpertmtbriftestatlowerlevelofhealthsysteminindia |
| _version_ |
1718421717486927872 |